Financhill
Back

Freeport-McMoRan Vs. Monopar Therapeutics Industry Stock Comparison

Sell
42

FCX
Freeport-McMoRan

Last Price:
$39.02
Seasonality Move:
-1.18%
Sell
46

MNPR
Monopar Therapeutics

Last Price:
$35.85
Seasonality Move:
-21.85%
Sell
42
Freeport-McMoRan (FCX) is a Sell

Is Freeport-McMoRan a Buy, Sell or Hold?

  • The current Freeport-McMoRan [FCX] share price is $39.02. The Score for FCX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • FCX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Monopar Therapeutics (MNPR) is a Sell

Is Monopar Therapeutics a Buy, Sell or Hold?

  • The current Monopar Therapeutics [MNPR] share price is $35.45. The Score for MNPR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FCX Stock Price Chart

What is Freeport-McMoRan's stock price today?

  • The Freeport-McMoRan share price today is $39.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FCX is experiencing buying pressure, which is a positive indicator for future bullish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics's stock price today?

  • The Monopar Therapeutics share price today is $35.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.

FCX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.65 Buy
Relative Strength Index (14 RSI): 57.8 Buy
Chaikin Money Flow: 14434566 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.9 - 38.92) Buy
Bollinger Bands (100): (34.96 - 39.92) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.81 Sell
Relative Strength Index (14 RSI): 44.33 Sell
Chaikin Money Flow: 3434 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.47 - 42.99) Sell
Bollinger Bands (100): (29.48 - 43.48) Sell

FCX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.44 Buy
20-day SMA: 37.91 Buy
50-day SMA: 36.95 Buy
200-day SMA: 40.95 Sell
8-day EMA: 38.36 Buy
20-day EMA: 37.77 Buy
50-day EMA: 37.3 Buy
200-day EMA: 39.99 Sell

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.76 Sell
20-day SMA: 38.94 Sell
50-day SMA: 37.88 Sell
200-day SMA: 24 Buy
8-day EMA: 36.5 Sell
20-day EMA: 37.75 Sell
50-day EMA: 37.47 Sell
200-day EMA: 27.12 Buy

Freeport-McMoRan Earnings Growth & FCX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.10 per share, an increase this year of $0.13 per share, and an increase next year of $0.60 per share.

Monopar Therapeutics Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.53 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.77 per share, and an increase next year of $0.41 per share.

Freeport-McMoRan Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):